Central precocious puberty in a toddler with hypothalamic hamartoma
In patients under the age of 4 years showing signs of CPP, HH should be considered as diagnosis. All patients receiving medical treatment should be closely monitored.
Authors
- Gönül Büyükyılmaz (ORCID: https://orcid.org/0000-0001-7888-7295)
- Mehmet Boyraz (ORCID: https://orcid.org/0000-0002-4289-9128)
- Banu Turhan (ORCID: https://orcid.org/0000-0001-8474-6835)
Institutions
- Bilkent University (TR)
- City Hospital (GB)
Publication Details
- Journal
- Journal of Pediatric Endocrinology and Metabolism
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1515/jpem-2024-0273
- Primary Topic
- Pharmacological Effects and Toxicity Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00